Julia Brodsky

Dr. Brodsky has over 20 years of experience centered on the pharmaceutical industry, with a special focus on data innovations and digital transformation. She is currently Vice President of Strategic Data Products at Novartis US Oncology, leading a team responsible for driving data innovations to accelerate digital transformation and leveraging data as a strategic asset. She also has experience in Market Access and Analytics within Novartis, giving her both insight into the pressing need for better evidence management platforms and the experience to integrate transformative platforms across large organizations.

Before Novartis, Dr. Brodsky served on several management teams, including AT&T Labs, Sanofi, Organon, and Symphony Health Solutions. Along with her education– she holds a PhD and Masters degree in Statistics from NYU, as well as a Bachelor’s in Computer Science–these experiences gave her deep expertise in data strategy, data enablement, predictive and descriptive analytics across the pharmaceutical development cycle, cloud-based infrastructure, and tech-enabled organizational growth and execution. She has been an appointed National Pharmaceutical Council Board member to represent Novartis, and served as a Pharmaceutical Management Science Association Elected Board Member.